Home / Musculoskeletal system / Orphenadrine, Combinations
ATC M03BC51 · Ethers, Chemically Close To Antihistamines · updated 2 Nov 2026
Orphenadrine, Combinations shortage
As of 2 Nov 2026, Orphenadrine, Combinations has a reported shortage in 1 of the 16 countries we track (Czechia), covering 1 product from 1 company.
Is there an Orphenadrine, Combinations shortage?
Yes. As of 2 Nov 2026, Orphenadrine, Combinations is reported short in 1 of the 16 countries we track: Czechia. The earliest expected return is 4 Dec 2026 (Czechia).
Timeline
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesListed: Fresenius Kabi FRE · Xetra
Affected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | NEODOLPASSE 75MG/30MG 75MG/30MG INF SOL 10X250ML | Fresenius Kabi s.r.o., Praha | 17 Jun 2026 | 4 Dec 2026 | Distribution or logistics Kapacitní/distribuční důvody |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.
Questions
Is there an Orphenadrine, Combinations shortage?
Yes. As of 2 Nov 2026, Orphenadrine, Combinations is reported short in 1 of the 16 countries we track: Czechia. The earliest expected return is 4 Dec 2026 (Czechia).
When will Orphenadrine, Combinations be back in stock?
Companies expect supply back from 4 Dec 2026 in Czechia; Czechia: 4 Dec 2026. These are company estimates reported to each authority.
Why is Orphenadrine, Combinations in short supply?
The most common reason reported is: distribution or logistics. Reasons by product are listed in the table below.
Which companies have Orphenadrine, Combinations shortages?
Fresenius Kabi.